Takenaka M, Tanimura H, Kamata T, Setoyama M
Jpn J Antibiot. 1977 Nov;30(11):893-7.
Sustained release cephalexin (S-6436) was studied in 23 outpatients (20 males, 3 females) who visited surgery of our hospital. The summary of the study is as follows: 1) The drug was administered for 2 approximately 8 days and the average was 3.5 days. Clinical effectiveness was 87.0% with the following breakdown: excellent 4, good 16, and poor 3. 2) Causative organisms isolated from the patients showing excellent effectiveness were all staphylococci. 3) No side effects were observed in any patients receiving the drug. From the above results, it is expected that S-6436 has good effectiveness and can be used as a first choice drug to outpatients with mild infections such as superficial infections who want to go to the office or school over their receiving the treatment.
对我院外科门诊的23例门诊患者（20例男性，3例女性）进行了缓释头孢氨苄（S-6436）的研究。研究总结如下：1）给药约2至8天，平均为3.5天。临床有效率为87.0%，具体分类如下：优4例，良16例，差3例。2）疗效优异的患者分离出的病原菌均为葡萄球菌。3）接受该药物治疗的患者均未观察到副作用。从上述结果来看，预计S-6436具有良好的疗效，可作为轻度感染（如体表感染）的门诊患者在接受治疗期间想去上班或上学时的首选药物。
